甘精胰岛素及其注射液是一种新型的胰岛素类似物,具有长效、血药浓度无峰值、平稳地降低患者血糖的作用。法国赛诺菲安万特公司是其原研生产厂家,商品名为来得时(lantus)。分别于2000年4月和6月由美国食品药品管理局(FDA)和欧洲医药产品评审委员会批准用于治疗1型和2型糖尿病。2004年...
Offers information on Lantus, a therapy that was developed to treat diabetes mellitus. Prevalence of diabetes cases in the U.S., according to the Centers for Disease Control and Prevention; Background on diabetes mellitus; Methods used in the diagnosis of diabetes; Primary effect of Lantus....
甘精胰岛素由赛诺菲(Sanofi)研发,于2000年4月20日获得美国食品药品监督管理局(FDA)批准,2000年6月9日获得欧洲药物管理局(EMA)批准,2003年11月7日获得中国食品药品监督管理局(CFDA)批准,2008年1月30日获得日本医药品医疗器械综合机构(PMDA)批...
Lantus, en todo el mundo. La mayoría de las empresas fabricantes de medicamentos para la diabetes consideran que el país es un mercado crítico para mejorar las ventas globales en general. Lantus es la insulina basal que se administra con más frecuencia en todo el mundo y representa...
Brands: Lantus, Admelog, Toujeo (vial only), Apidra Lowest price: $99 per month for any combination of up to 10 vials and/or boxes of pens, for up to 12 months. Eligibility: Uninsured patients only More info: Check out the Insulins Valyou Savings Program website. Sanofi Patient Assista...
属于长效胰岛素类似物,通过修饰延长作用时间,用于基础胰岛素补充,作用时间约12-24小时,不属于速效型。2. **选项B:Lantus(Insulin Glargine)** 同为长效胰岛素类似物,作用时间长达24小时,提供稳定的基础胰岛素水平,非速效型。3. **选项C:Aspart Insulin** 速效胰岛素类似物,通过结构改造加快起效时间,通常10-20分...
A phase 2 trial compared the new weekly insulin, called icodec, to the commonly used insulin glargine (Lantus, Basaglar), and found the new insulin led to a similar reduction inblood sugar levels. The weekly insulin also had a similar safety profile to daily insulin glargine. ...
injection of insulin glargine (Lantus, Sanofi S.A., Paris, France) in conjunction to feeding, based on individual plasma glucose curves, to maintain target fasting plasma glucose of 9–12 mM. Pigs were fed 460 g of feed once-daily (SDS minipig, Special Diets Service, Essex, UK) and ...
Because of the development of basal insulin, such as insulin glargine (IGlr; Lantus®, a long-acting insulin analogue) and insulin degludec (IDeg, Tresiba®, an ultra-long-acting insulin analogue), the basal-bolus insulin regimen is generally used for glucose control because it more closely...
They were divided into three groups:continuous subcutaneous insulin infusion(CSⅡ) group,long-acting insulin(Lantus) group and continuous intravenous insulin infusion(CVⅡ) group. 方法:选择接受外科手术且术后禁食或进食不规律的2型糖尿病患者,分设胰岛素泵(CSⅡ)组、长效胰岛素(来得时)组和持续静脉输注...